Nurse Practitioner, Family · New York, NY
NPI
1568814135
Since 2016
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1 Park Ave Fl 11
New York, NY, 10016
Phone (212) 263-7951
Groups this clinician bills Medicare through
Medicare paid, 2024
$199K
7,434 services
Medicare patients, 2024
97
Average age 74
Drug cost, 2024
$1.0M
2,367 prescriptions
Company payments, 2025
$14.54
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tsering Y Tenzing was code J2182 (injection, mepolizumab, 1 mg), 3,200 times for 13 patients. In total Tsering Y Tenzing billed 7,434 services in 20 codes, and Medicare paid $199K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-02-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2182 Injection, mepolizumab, 1 mg | Office | 3,200 | 13 | $23.88 | $76K |
| 96372 Injection Administration | Office | 80 | 32 | $10.91 | $873 |
| 99213 Office E&M - Established | Office | 65 | 44 | $66.52 | $4,324 |
| 99214 Office E&M - Established | Office | 33 | 29 | $92.04 | $3,037 |
| 36415 Venipuncture Blood Collection | Office | 15 | 11 | $8.65 | $130 |
By year: 2022 $665K for 24,934 services; 2023 $356K for 14,053 services; 2024 $199K for 7,434 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 15 | 11 | $8.65 | $130 |
Medicare prescription drug claims, 2024
In 2024, the drug Tsering Y Tenzing prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 236 prescriptions and refills. In total Tsering Y Tenzing wrote 2,367 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 236 | 295 | 55 | $186K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 211 | 310 | 78 | $7,594 |
| Montelukast Sodium Generic | 198 | 532 | 63 | $2,494 |
| Prednisone Generic | 133 | 139 | 83 | $514 |
| Breo Ellipta Fluticasone/Vilanterol | 121 | 163 | 35 | $62K |
| Advair Hfa Fluticasone Propion/Salmeterol | 116 | 172 | 27 | $58K |
| Spiriva Respimat Tiotropium Bromide | 87 | 125 | 21 | $63K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 76 | 98 | 18 | $44K |
| Famotidine Generic | 73 | 151 | 23 | $1,207 |
| Arnuity Ellipta Fluticasone Furoate | 71 | 96 | 24 | $22K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 66 | 74 | Under 11 | $35K |
| Incruse Ellipta Umeclidinium Bromide | 61 | 68 | 16 | $23K |
| Omeprazole Generic | 54 | 97 | 16 | $953 |
| Fluticasone Propionate Generic | 49 | 113 | 22 | $960 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 48 | 82 | 15 | $8,567 |
Brand drugs: 1,474 claims; generic drugs: 893 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tsering Y Tenzing $14.54 ($14.54 in general payments such as food, travel and fees) from 1 company. The largest payer was GlaxoSmithKline, LLC. with $14.54.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 1 | $14.54 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.